PATENT CLAIM ANALYSIS

Application Number: 16087580
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["514", "249000"]

Abstract:
The present invention pertains to the technological sector of the pharmaceutical industry and, more specifically, refers to a second use composition intended for the treatment of a dermatology condition called Poikiloderma of Civatte. The solution proposed in this document is the use of a topical composition containing any substance alone or in combination from the pharmacological group of alpha-adrenergic receptor agonists in therapeutic quantities to treat color of the lesions of Poikiloderma of Civatte. The application of this composition for the condition of Poikiloderma of Civatte results in significant improvement of the color of the skin lesions, also improving the vascular component present in this condition and can be associated with other compounds.

Claim (Index 2):
Use of a pharmaceutical composition for the treatment of poikilodermas according to  claim 1 , wherein the active substance is from the group of alpha-adrenergic receptor agonists such as, but not limited to, the following substances: apraclonidine, brimonidine, clonidine, desglymidodrine, dexmedetomidine, dopamine, ephedrine, epinephrine, epinine (N-methyl dopamine), ethylnorepinephrine, phenylephrine, phenylpropanolamine, guanabenz, guanfacine, 1-dobutamine, levarterenol, lofexidine, mephentermine, metaraminol, methylphenidate, methoxamine, midodrine, mytodrine, mivazerol, moxonidine, naphazoline, norepinephrine, norphenylephrine, oxymetazoline, pemoline propylhexedrine, propylhexedrine, tetryzoline, tizanidine, xylometazoline, \u03b1-methyldope, \u03b1-methylnorepinephrine, (4.5-dihydro-1H-imidazol-2-yl)-(quinoxaline-8-methyl-6-yl)-amine, (4.5-dihydro-1h-imidazol-2-yl) quinoxaline-5-yl-amine, (5-bromo-2-methoxy-quinoxaline-6-yl)-(4.5-dihydro-1h-imidazol-2-yl)-amine, (5-bromo-3-methyl-6-yl) quinoxaline-(4.5-dihydro-1h-imidazol-2-yl)-amine, (8-bromo-quinoxalin-5-yl)-(4.5-dihydro-1h-imidazol-2-yl)-amine, (8-bromoquinoxalin-6-yl)-(4.5-dihydro-1h-imidazol-2-yl)-amine.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.75
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13821145', '13785802', '13309403', '13233891', '15457362']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7734092641967344
- 35 USC 102 Novelty (BERT): 0.4916466988804769
- Combined Prediction Score: 0.7452330076651087
- Mean Citation Score: 215.958632
- Max Citation Score: 227.17429
- Similarity Product: 172.4949940977067

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test